A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: One-half of patients significantly mobilize malignant cells

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 631-637

  Jacquy, C ^a   Soree A ^a   Lambert, F ^a   Bosly, A ^b   Ferrant, A ^b   Andre M ^b   Parma, J ^a   Kentos, A ^a   Martiat, P ^a,c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

Diffuse large cell lymphoma; Minimal residual disease; PBSC

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DNA; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MELPHALAN; PREDNISONE; VINDESINE;

ARTICLE; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTAMINATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

BONE MARROW CELLS; GENE REARRANGEMENT; GENETIC MARKERS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; RECURRENCE;

EID: 0033781235     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02244.x     Document Type: Article

References (26)

1. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease
2. Description of a novel FR1 IGH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies
3. Intensive chemotherapy plus hematopoietic stem cells transplantation for relapsing non-Hodgkin's lymphoma: The GELA experience
4. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin lymphomas treated with high-dose chemotherapy and peripheral blood progenitor autografting
5. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
6. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH 87-2
7. High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma
8. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation
9. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
10. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse
11. Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: The case for purging?
12. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma
13. Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia
14. Optimal primer selection for clonality assessment by polymerase chain reaction analysis. III. Intermediate and high-grade B-cell neoplasms
15. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: A new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data
16. High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma
17. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IGH probes and the polymerase chain reaction
18. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: A description of the method and the principles involved
19. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma
20. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
21. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest
22. Quantitation of targets for PCR by use of limiting dilution
23. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with poor prognosis
24. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry
25. The detection of minimal lymphoma by molecular and combined culture-molecular methods
26. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation